A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Ralinepag to Evaluate Safety and Effects on Exercise Capacity Assessed by Cardiopulmonary Exercise Testing in Subjects with World Health Organization Group 1 Pulmonary Hypertension Who Recently Initiated Therapy
- Brown, Martin (Primary Chief Investigator)
- Chapman, Nicola, (Clinical Trial Unit Staff)
- Rai, Meenal, (Clinical Trial Unit Staff)
- Parshionikar, Abhijit, (Clinical Trial Unit Staff)
Project: Research